We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
98 hedge funds and large institutions have $493M invested in Accelerate Diagnostics in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
37% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 27
17% more capital invested
Capital invested by funds: $421M → $493M (+$71.1M)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
10% less funds holding
Funds holding: 109 → 98 (-11)
33% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 18
60% less call options, than puts
Call options by funds: $2.91M | Put options by funds: $7.33M
Holders
98
Holders Change
-11
Holders Change %
-10.09%
% of All Funds
2.44%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
12
Increased
37
Reduced
27
Closed
18
Calls
$2.91M
Puts
$7.33M
Net Calls
-$4.42M
Net Calls Change
-$826K
Top Buyers
| 1 |
BlackRock
New York
|
+$33.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.85M |
| 3 |
MGM
Miura Global Management
New York
|
+$6.4M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$5.48M |
| 5 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$5.28M |
